1989–1995 Faculty of Medicine, University of Belgrade. Graduated with an average grade of 9.33.
1995–2000 Master's studies in pulmonology - Faculty of Medicine, University of Belgrade.
1996–2000 Specialization in pediatrics - Faculty of Medicine, University of Belgrade. Specialist exam passed before the commission of the Institute for Health Care of Mother and Child of Serbia with excellent results.
2004 Master's thesis defended in pulmonology entitled: "The influence of inhaled corticosteroids on the linear growth of children with asthma". Faculty of Medicine, University of Belgrade.
2013 Defended doctoral dissertation (narrower scientific field of pulmonology) entitled: "Estimation of aerobic capacity and respiratory reserve index of patients with cystic fibrosis". Faculty of Medicine, University of Belgrade.
2016 Defended thesis of narrow specialization in pulmonology entitled: "Examination of respiratory muscle strength in patients with cystic fibrosis in relation to the level of effort tolerance during ergospirometry". Faculty of Medicine, University of Belgrade.
MOVEMENT IN SERVICE
2000 – Doctor in the Service for Examination and Treatment of Lung Diseases, Institute for Health Care of Mothers and Children of Serbia.
SCHOLARSHIPS AND TRAINING ABROAD
2003 (March – June) Department of pulmonology and pediatric intensive care. Pediatric Clinic, Mt. Sinai Hospital, Mt. Sinai School of Medicine, New York, USA.
2003 (June) Department of Pediatric Pulmonology, Pediatric Clinic, Children's Hospital, Columbia University, New York, USA.
2003 Course: "Advanced pediatric respiratory medicine" - European Respiratory School
Association ("European respiratory society" - ERS) - participation supported by a scholarship from ERS - Barcelona, Spain.
2004 Course "Cystic fibrosis - state of the art" - School of the European Respiratory Association - Vienna, Austria.
2005 (August) Department of Pediatric Pulmonology and Center for Cystic Fibrosis. Hôpital d̓ enfants Armand Trousseau, Paris, France.
2005 Course "Non-invasive positive pressure ventilation - state of the art" - School ERS. participation supported by ERSa scholarship - Pisa, Italy.
2006 6th pediatric bronchology course – Imperial College and Royal Brompton hospital, London, UK.
2006 Course "Basic principles of clinical exercise testing" – School of the European Respiratory Association – Rome, Italy
2007 Course "Infant pulmonary function testing" - School of the European Respiratory Association - Nice, France.
2016 The European Workshop on Clinical Pediatric Exercise Testing (EWCPET 2016) – Utrecht, The Netherlands
SCHOLARSHIPS AND TRAINING IN THE COUNTRY
2007 Good Clinical Practice Course - Association of Professionals in Clinical Trials (ACRP), Belgrade.
2014 Scoring Course PG Basic, Polygraphy – Belgrade, Serbia
2015 Scoring Course PG Advanced, Polygraphy – Belgrade, Serbia
MEMBERSHIPS
European Respiratory Society
European Cystic Fibrosis Association
American Thoracic Society
Association of Pediatricians of Serbia
Association for Cystic Fibrosis of Serbia
Association of clinical research professionals ("Association of clinical research professionals")
PARTICIPATION IN INTERNATIONAL MULTICENTRIC CLINICAL STUDIES
Efficacy and safety of ciclesonide in adolescents with asthma. A randomized, double-blind, double dummy, parallel group, multicenter study. ESSENCE BY 9010/M1-139. INVESTIGATOR.
Treatment of asthma in pediatric patients. Comparation of inhaled ciclesonide 160 mcg/day and budesonide 400 mcg/day. PeP-Study. BY9010/M1-204. INVESTIGATOR.
Safety and tolerability study of SLIT™ Amikacin 500 mg once daily for 14 days by inhalation in cystic fibrosis study subjects chronicaly infected with pseudomonas aeruginosa. TR02-103. INVESTIGATOR.
A Randomized, Double-blind Placebo-controlled, Multicenter, Phase 3 trial to Assess the Efficacy and Safety of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis (CF) Subjects. TIP002 Study. INVESTIGATOR.
Pharmacokinetics of the pharmacologically active metabolite M1 of ciclesonide after inhalation of ciclesonide via MDI with and without AeroChamber Plus spacer in asthmatic children. BY9010/CP-037. INVESTIGATOR
Multidose safety nad tolerability study of dose escalation of liposomal amikacin for inhalation (ARIKACE) in cystic fibrosis patients with chronic infection due to pseudomonas aeruginosa TR02-105. INVESTIGATOR.
A Phase III, randomized, double-blind, placebo-controlled clinical study evaluating the efficacy and safety of ALTU-135 treatment in patients with cystic fibrosis-related exocrine pancreatic insufficiency. INVESTIGATOR.
A Open-Label clinical study evaluating the long-term safety of ALTU-135 for the treatment of patients with cystic fibrosis-related exocrine pancreatic insufficiency. INVESTIGATOR.
Multidose safety nad tolerability study of dose escalation of liposomal amikacin for inhalation (ARIKACE) in cystic fibrosis patients with chronic infection due to pseudomonas aeruginosa TR02-105 – Extension study. INVESTIGATOR.
Randomized open-label, active-controlled, multicenter study to assess the efficacy, safety and tolerability of Arikace in cystic fibrosis patients with chronic infection due to Pseudomonas aeruginosa TR02-108. INVESTIGATOR.
Long Term Safety and Tolerability of Open-Label Liposomal Amikacin for Inhalation (Arikace™) in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa TR02-110. INVESTIGATOR.
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects DPM‐CF‐303. PRINCIPAL INVESTIGATOR
A Phase III, Randomiyed, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-3641, a Ragweed (Ambrosia artemisiifolia) Sublingual Immunotherapz Tablet, in Children With History of Ragweed – Induced Rhinoconjunctivitis With or Without Asthma. INVESTIGATOR
A Phase IIa, Randomized, Double-blind, Placebo-controlled Study to Evaluate Multiple Doses of GLPG2222 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation. INVESTIGATOR
„A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy in GINA steps 3, 4 and 5 patients with uncontrolled asthma“
A phase 2 study of ABBV-3067 Alone and in Combination with ABBV-2222 in Cystic fibrosis Subjects who are Homozygous for the F508del mutation. INVESTIGATOR.
PARTICIPATION IN PROJECTS
Project "Primary health care of mother and child" - educational seminars for doctors in primary health care, Project holder: Institute for health care of mother and child of Serbia, with the support of UNICEF. Expert lecturer for the topic: Acute respiratory infections, 2004-2005. years.
Project "Rational use of antibiotics in pediatrics". Project holder: Ministry of Health of the Republic of Serbia and Association of Pediatricians of Serbia, 2016-2017.
MEMBERSHIP IN THE EDITORIAL BOARD OF SCIENTIFIC PUBLICATIONS
1997 "Problems in Pediatrics"
REVIEWER OF SCIENTIFIC PUBLICATIONS
Frontiers in Pediatrics
Respiratory Care
OTHER SKILLS
I write, read and speak English
I speak French
MORE SIGNIFICANT REFERENCES IN PROFESSIONAL PUBLICATIONS
Sovtic A. Diagnosis of cystic fibrosis-related diabetes: too early or too late? J Brasil Pneumol 2022; 20:48.
Markovic-Sovtic G, Djuricic S, Sovtic A, Minic P, Rakonjac Z, Colmero I. Neonatal generalized lymphatic anomaly (GLA) with skin involvement. Ann Dermatol 2021.
Sovtic A, Grba T, Grahovac D, Minic P. Flexible Bronchoscopy in Evaluation of Persistent Wheezing in Children — Experiences from the National Pediatric Center. Medicine 2020; 56: 329.
Basa M, Minic P, Rodic M, Sovtic A. (corresponding author). Evolution of pediatric home mechanical ventilation program in Serbia – what has changed in the last decade. Front Ped 2020; 8:261. M21, IF 2,349.
Plavsic L, Knezevic M, Sovtic A, Minic P, Vukovic R, Mazibrada I, Stanojlovic O, Hrncic D, Rasic-Markovic A, Macut D. Effects of high-intensity interval training and nutrition advice on cardiometabolic markers and aerobic fitness in adolescent girls with obesity. Appl Physiol Nutr Metab. 2020; 45: 294-300.
Paglietti M, Porcaro F, Sovtic A, Cherchi C, Verrillo E, Pavone M, Bottero S, Cutrera R. Decannulation in children affected by congenital central hypoventilation syndrome: A proposal of an algorithm from two European centers. Pediatr Pulmonol 2019; 54: 1663-9.
Anđelković M, Spasovski V, Vreća M, Sovtić A, Rodić M, Komazec J, Pavlović S, Minic P. The importance of genomic profiling for differential diagnosis of pediatric lung disease patients with suspected ciliopathies. Srp Arch Celok Lek 2019│Online First March 4, 2019.
Andjelkovic M, Minic P, Vreca M, Stojiljkovic M, Skakic A, Sovtic A, Rodic M, Skodric-Trifunovic V, Maric N, Visekruna J, Spasovski V, Pavlovic S. Genomic profiling supports the diagnosis of primary ciliary dyskinesia and reveals novel candidate genes and genetic variants. PLoS One. 2018 Oct 9;13(10):e0205422.
Sovtic A, Minic P, Markovic-Sovtic G, Trajkovic G. Respiratory muscle strength and exercise performance in cystic fibrosis–A cross sectional study. Front Pediatr 2018; 6:244.
Radtke T, Hebestreit H, Gallati S, Schneiderman JE, Braun J, Stevens D, Hulzebos EH, Takken T, Boas SR, Urquhart DS, Lands LC, Tejero S, Sovtic A, et al. CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study. Ann Am Thorac Soc 2018;15(2):209-216.
Malešević M, Vasiljević Z, Sovtić A, Filipić B, Novović K, Kojić M, Jovčić B. Virulence traits associated with Burkholderia cenocepacia ST856 epidemic strain isolated from cystic fibrosis patients. Antimicrob Resist Infection Control. 2017 June 6;6:5.
Minic P, Sovtic A. Exercise intolerance and exercise-induced bronchoconstriction in children. Front Biosci 2017; 9:21-32.
Vasiljevic Z, Novovic K, Kojic M, Minic P, Sovtic A, Djukic S, Jovcic B. Burkholderia cepacia complex in Serbian patients with cystic fibrosis: prevalence and molecular epidemiology. Eur J Clin Microbiol Infect Dis 2016; 35:1277-84.
Marković D, Perić T, Sovtić A, Minić P, Mirković B. State of oral health in children with asthma. Srp Arch Celok Lek 2015;143:539-44.
Baljosevic I, Minic P, Trajkovic G, Markovic-Sovtic G, Radojicic B, Sovtic A (corresponding author). Evaluation of surgical treatment of severe laryngomalacia – follow-up study. Pediatr Int 2015; 57:1159-63.
Sovtic A, Minic P, Kosutic J, Markovic-Sovtic G, Gajic M. Modified Chrispin-Norman score: correlation with peak exercise capacity and efficiency of ventilation in children with cystic fibrosis. Pediatr Exerc Sci 2014; 26:259-65.
Markovic-Sovtic G, Kosutic J, Jankovic B, Bojanin D, Sovtic A, Radojicic Z, et al. NT-pro BNP In Assessment Of Respiratory Distress In Term Neonates. Pediatr Int 2014; 56:373-7.
Sovtic A, Minic P, Kosutic J, Markovic-Sovtic G, Gajic M. Static hyperinflation is associated with decreased exercise performance in children with cystic fibrosis. Respir Care 2013; 58:291–7.
Radivojevic D, Sovtic A, Minic P, Grkovic S, Guc-Scekic M, Lalic T, et al. Newborn screening for cystic fibrosis in Serbia – a pilot study. Pediatr Int 2013; 55:181-4.
Sovtic A, Minic P, Vukcevic M, Markovic-Sovtic G, Rodic M, Gajic M. Home mechanical ventilation in children is feasible in developing countries. Pediatr Int 2012; 54:676-81.
Kosutic J, Minic P, Sovtic A, Prijic S. Upper lung lobe systemic artery-pulmonary vein fistula with signs and symptoms of congestive heart failure: successful treatment with coil embolization. J Vasc Interv Radiol 2007; 18:299-302.
Sovtić A, Minic P, Bogdanović R, Stajić N, Rodić M, Marković-Sovtić G. Atypical presentation of cystic fibrosis – obese adolescent with hypertension and Pseudo-Bartter's syndrome. Vojnosanit Pregl 2012; 64:367-9.
